Back to top
more

Bristol-Myers Squibb Company (BMY)

(Delayed Data from NYSE)

$58.51 USD

58.51
10,165,908

-0.28 (-0.48%)

Updated Nov 14, 2019 04:00 PM ET

Add to portfolio

2-Buy   2      

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.62%
17.69%
9.40%
5.11%
2.01%
10.65%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

B Value | B Growth | F Momentum | B VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Balance Sheet

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

Research for BMY

   

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

Fiscal Year End for Bristol-Myers Squibb Company falls in the month of December.

All items in Millions except Per Share data.

12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Assets          
Cash & Equivalents 8,884 6,812 6,350 4,270 7,435
Receivables 5,965 6,300 5,543 4,299 3,390
Notes Receivable 0 0 0 0 0
Inventories 1,195 1,166 1,241 1,221 1,560
Other Current Assets 1,116 576 570 625 2,223
Total Current Assets 17,160 14,854 13,704 10,415 14,608
Net Property & Equipment 5,027 5,001 4,980 4,412 4,417
Investments & Advances 1,775 2,480 2,719 4,660 4,408
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 1,371 1,610 2,996 2,844 915
Intangibles 7,629 8,073 8,260 8,300 8,780
Deposits & Other Assets 2,024 1,533 1,048 1,117 621
Total Assets 34,986 33,551 33,707 31,748 33,749
Liabilities & Shareholders Equity 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Notes Payable 0 0 0 0 0
Accounts Payable 1,892 2,248 1,664 1,565 2,487
Current Portion Long-Term Debt 1,703 987 992 139 590
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 6,489 6,014 5,271 4,083 3,310
Income Taxes Payable 398 231 152 572 262
Other Current Liabilities 172 83 762 1,658 1,812
Total Current Liabilities 10,654 9,563 8,841 8,017 8,461
Mortgages 0 0 0 0 0
Deferred Taxes/Income 3,511 4,002 1,520 1,328 1,330
Convertible Debt 0 0 0 0 0
Long-Term Debt 5,646 6,975 5,716 6,550 7,242
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1,048 1,164 1,283 1,429 1,733
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 20,859 21,704 17,360 17,324 18,766
Shareholders Equity 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Preferred Stock 0 0 0 0 0
Common Stock (Par) 221 221 221 221 221
Capital Surplus 2,081 1,898 1,725 1,459 1,507
Retained Earnings 34,065 31,160 33,513 31,613 32,541
Other Equity -2,666 -2,183 -2,333 -2,310 -2,294
Treasury Stock 19,574 19,249 16,779 16,559 16,992
Total Shareholder's Equity 14,127 11,847 16,347 14,424 14,983
Total Liabilities & Shareholder's Equity 34,986 33,551 33,707 31,748 33,749
Total Common Equity 14,127 11,847 16,347 14,424 14,983
Shares Outstanding 1,632.40 1,636.70 1,671.20 1,668.20 1,658.70
Book Value Per Share 8.65 7.24 9.78 8.65 9.03

Fiscal Year End for Bristol-Myers Squibb Company falls in the month of December.

All items in Millions except Per Share data.

9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Assets          
Cash & Equivalents 32,542 29,357 8,764 8,884 6,830
Receivables 5,510 5,667 5,704 5,965 5,871
Notes Receivable 0 0 0 0 0
Inventories 1,192 1,308 1,283 1,195 1,282
Other Current Assets 947 1,384 1,342 1,116 886
Total Current Assets 40,191 37,716 17,093 17,160 14,869
Net Property & Equipment 4,830 4,849 4,985 5,027 5,092
Investments & Advances 925 994 1,233 1,775 2,017
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 1,624 1,442 1,380 1,371 1,627
Intangibles 7,515 7,528 7,562 7,629 7,793
Deposits & Other Assets 2,348 2,634 2,581 2,024 2,336
Total Assets 57,433 55,163 34,834 34,986 33,734
Liabilities & Shareholders Equity 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Notes Payable 0 0 0 0 0
Accounts Payable 1,888 2,005 1,976 1,892 1,773
Current Portion Long-Term Debt 569 545 381 1,703 1,620
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 8,032 7,161 5,856 6,489 5,853
Income Taxes Payable 0 0 525 398 355
Other Current Liabilities 0 0 103 172 93
Total Current Liabilities 10,489 9,711 8,841 10,654 9,694
Mortgages 0 0 0 0 0
Deferred Taxes/Income 2,919 2,971 3,532 3,511 3,598
Convertible Debt 0 0 0 0 0
Long-Term Debt 24,390 24,433 5,635 5,646 5,687
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1,881 1,509 1,048 1,005
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 39,679 39,012 19,517 20,859 19,984
Shareholders Equity 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Preferred Stock 0 0 0 0 0
Common Stock (Par) 221 221 221 221 221
Capital Surplus 2,206 2,150 2,103 2,081 2,029
Retained Earnings 36,555 35,870 35,109 34,065 33,292
Other Equity -1,357 -2,519 -2,545 -2,666 -2,216
Treasury Stock 19,871 19,571 19,571 19,574 19,576
Total Shareholder's Equity 17,754 16,151 15,317 14,127 13,750
Total Liabilities & Shareholder's Equity 57,433 55,163 34,834 34,986 33,734
Total Common Equity 17,754 16,151 15,317 14,127 13,750
Shares Outstanding 1,629.20 1,635.70 1,635.70 1,632.40 1,632.20
Book Value Per Share 10.90 9.87 9.36 8.65 8.42